Initial experience of total laparoscopic radical resection for Bismuth type Ⅲ a hilar cholangiocarcinoma: a report of three cases
10.3760/cma.j.issn.1007-8118.2018.09.010
- VernacularTitle:完全腹腔镜下Bismuth Ⅲa型肝门部胆管癌根治术三例
- Author:
Hanhui CAI
1
,
2
;
Zhiming HU
;
Jie LIU
;
Yuanbiao ZHANG
;
Yuhua ZHANG
;
Guoliang SHEN
;
Kai JIANG
;
Chengwu ZHANG
;
Weiding WU
Author Information
1. 310014 杭州,浙江省人民医院 杭州医学院附属人民医院肝胆胰外科及微创外科
2. 浙江中医药大学
- Keywords:
Hilar cholangiocarcinoma;
Laparoscopic surgery;
Radical resection;
Bismuth Ⅲ a
- From:
Chinese Journal of Hepatobiliary Surgery
2018;24(9):613-615
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the initial experience of total laparoscopic radical resection for patients with Bismuth type Ⅲa hilar cholangiocarcinoma.Methods A retrospective study was conducted to analyze the clinical data of three patients with Bismuth type Ⅲa hilar cholangiocarcinomatotal who underwent laparoscopic radical resection in Zhejiang Provincial People's Hospital from February to May in 2017.Results The three patients all underwent the operations successfully.The operation time ranged from 490.0 to 580.0 min.The intraoperative blood loss ranged from 300.0 ml to 1 200.0 ml.There was no severe perioperatire complication or death.One patient developed biliary leakage which responded to drainage without reoperation.Another patient developed pleural effusion treated with minimal invasive drainage.The length of postoperative hospital stay ranged from 10.0 to 18.0 days.Histopathology showed two patients with well-differentiated adenocarcinomas and one patient with poorly differentiated adenocarcinoma.The number of lymph nodes harvested ranged from 8 ～ 13.Two patients had no regional lymph node metastasis and one patient had regional lymph node metastasis (1/13).The hilar bile duct resection margins of the three patients were all negative.There was no evidence of tumor recurrence on following up for 7 ～ 10 months.Conclusions It was safe and feasible to carry out total laparoscopic radical resection in selected patients with Bismuth type Ⅲa hilar cholangiocarcinoma.More patients and longer follow-up are required to study the long term oncological results.
